Welcome to DrugFinder

The DrugFinder Service is a joint venture between InhibOx Ltd. and the National Foundation for Cancer Research (NFCR). DrugFinder provides a service to the drug discovery community that identifies potentially active molecules against a target protein using our in-house virtual screening methods, which build on our collaboration with the highly successful Screensaver Lifesaver.

DrugFinder is easy to use. Users submit their target through a web form, including the structure of a known protein-ligand complex, to our virtual screening system. DrugFinder then searches through CSPACE, our carefully curated library of about 900,000 commercially-available, drug-like molecules. When the screening is finished, we return a list of putative inhibitors by email, along with information about their suppliers.

The service is confidential with the resulting intellectual property remaining that of the group which submits the task.

Three levels of virtual screening are supported:

	The user's crystal structure of a receptor and bound ligand will be used to query InhibOx's database of commercially-available molecules : the top 100 ligands are returned. The Bronze service is offered free of charge. Priority will be given to cancer-related projects.
	This is a two stage service that expands on the Bronze level, where the user selects several of the top hits and submits a set of substructure queries to screen related molecules from the larger set of molecules in CSPACE.
	The Gold service is a completely customized service, where InhibOx's suite of tools is available for the construction of a made-to-order workflow. Lead optimization is also offered.

20% of proceeds from DrugFinder will go to NFCR to support cancer research.